Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - propranolol hydrochloride, quantity: 40 mg - tablet - excipient ingredients: povidone; sodium starch glycollate; lactose monohydrate; quinoline yellow; magnesium stearate; maize starch; sunset yellow fcf aluminium lake; brilliant blue fcf aluminium lake - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - propranolol hydrochloride, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; povidone; sunset yellow fcf aluminium lake; magnesium stearate; quinoline yellow; sodium starch glycollate - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

Australia - English - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - propranolol hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: carmellose calcium; magnesium stearate; carmine; lactose monohydrate; hypromellose; gelatin; titanium dioxide; glycerol - 1. angina pectoris, 2. hypertension, 3. prevention of migraine, 4. cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (e.g. tachycardia due to digitalis or adrenaline overdosage), 5. essential tremor, including familial and senile tremor, 6.phaeochromocytoma (only with concurrent alpha-receptor blockade), 7. hypertrophic subaortic stenosis, 8. suspected or definite myocardial infarction, 9. fallot's tetralogy.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - propranolol hydrochloride, quantity: 40 mg - tablet - excipient ingredients: sunset yellow fcf aluminium lake; maize starch; lactose monohydrate; povidone; brilliant blue fcf aluminium lake; sodium starch glycollate; magnesium stearate; quinoline yellow - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline (epinephrine overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

United States - English - NLM (National Library of Medicine)

pierre fabre pharmaceuticals, inc. - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 4.28 mg in 1 ml - hemangeol oral solution contains the beta-adrenergic blocker propranolol hydrochloride and is indicated for the treatment of proliferating infantile hemangioma requiring systemic therapy. hemangeol is contraindicated in the following conditions: - premature infants with corrected age < 5 weeks - infants weighing less than 2 kg - known hypersensitivity to propranolol or any of the excipients [see description (11)] - asthma or history of bronchospasm - heart rate <80 beats per minute, greater than first degree heart block, or decompensated heart failure - blood pressure <50/30 mmhg - pheochromocytoma of 460 infants with proliferating infantile hemangioma requiring systemic therapy who were treated with hemangeol starting at 5 weeks to 5 months of age, 60% had complete or nearly complete resolution of their hemangioma at week 24 [see  clinical studies (14)]. safety and effectiveness for infantile hemangioma have not been established in pediatric

Australia - English - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - propranolol hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: carmellose calcium; carmine; magnesium stearate; gelatin; hypromellose; glycerol; titanium dioxide; lactose monohydrate - indications as at 05 mar 02 : 1. angina pectoris, 2. hypertension, 3. prevention of migraine, 4. cardiac dysrhythmias : certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (e.g. tachycardia due to digitalis or adrenaline overdosage), 5. essential tremor, including familial and senile tremor, 6.phaeochromocytoma (only with concurrent alpha-receptor blockade), 7. hypertrophic subaortic stenosis, 8. suspected or definite myocardial infarction, 9. fallot's tetralogy.

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - propranolol hydrochloride, quantity: 40 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; quinoline yellow; brilliant blue fcf aluminium lake; sunset yellow fcf aluminium lake; magnesium stearate; povidone; sodium starch glycollate - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

Australia - English - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - propranolol hydrochloride, quantity: 40 mg - tablet - excipient ingredients: lactose monohydrate; povidone; quinoline yellow; maize starch; brilliant blue fcf aluminium lake; sunset yellow fcf aluminium lake; magnesium stearate; sodium starch glycollate - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - propranolol hydrochloride, quantity: 40 mg - tablet - excipient ingredients: brilliant blue fcf aluminium lake; sodium starch glycollate; magnesium stearate; lactose monohydrate; maize starch; sunset yellow fcf aluminium lake; quinoline yellow; povidone - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - propranolol hydrochloride, quantity: 40 mg - tablet - excipient ingredients: maize starch; lactose monohydrate; magnesium stearate; sodium starch glycollate; brilliant blue fcf aluminium lake; sunset yellow fcf aluminium lake; quinoline yellow; povidone - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy